Study details
Enrolling now
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Trial
University of California, Los Angeles
NCT IDNCT06337942ClinicalTrials.gov data as of Apr 2026
Target enrollment
5
Study length
about 3 years
Ages
18–70
Locations
1 site in CA
What this study is about
This trial is testing whether it's possible to transplant a new bladder into people with terminal bladder diseases. The goal is to see if the transplanted bladder works properly and is safe for patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Bladder Transplantation
- 2.Undergo Combined Kidney and Bladder Transplantation
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Incidence of adverse events after bladder or combined kidney-bladder transplantation
Body systems
Renal, Oncology